Perrigo Company Company Profile (NYSE:PRGO)

About Perrigo Company (NYSE:PRGO)

Perrigo Company logoPerrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Related Products
  • Sub-Industry: Pharmaceuticals
  • Symbol: NYSE:PRGO
  • CUSIP: 71429010
  • Web:
  • Market Cap: $10.37623 billion
  • Outstanding Shares: 143,397,000
Average Prices:
  • 50 Day Moving Avg: $72.61
  • 200 Day Moving Avg: $75.14
  • 52 Week Range: $65.47 - $99.14
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 14.52
  • P/E Growth: 2.82
Sales & Book Value:
  • Annual Revenue: $5.13 billion
  • Price / Sales: 2.05
  • Book Value: $42.31 per share
  • Price / Book: 1.73
  • Annual Dividend: $0.64
  • Dividend Yield: 0.9%
  • EBIDTA: $1.12 billion
  • Net Margins: -43.81%
  • Return on Equity: 11.79%
  • Return on Assets: 5.43%
  • Debt-to-Equity Ratio: 0.76%
  • Current Ratio: 2.06%
  • Quick Ratio: 1.74%
  • Average Volume: 1.83 million shs.
  • Beta: 0.78
  • Short Ratio: 3.35

Frequently Asked Questions for Perrigo Company (NYSE:PRGO)

What is Perrigo Company's stock symbol?

Perrigo Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo Company pay dividends? What is the dividend yield for Perrigo Company?

Perrigo Company declared a quarterly dividend on Wednesday, May 3rd. Shareholders of record on Friday, May 26th will be paid a dividend of $0.16 per share on Tuesday, June 13th. This represents a $0.64 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date is Wednesday, May 24th. View Perrigo Company's Dividend History.

How were Perrigo Company's earnings last quarter?

Perrigo Company (NYSE:PRGO) announced its quarterly earnings data on Tuesday, May, 30th. The company reported $1.05 EPS for the quarter, beating the Zacks' consensus estimate of $0.99 by $0.06. The firm earned $1.19 billion during the quarter, compared to analyst estimates of $1.19 billion. Perrigo Company had a negative net margin of 43.81% and a positive return on equity of 11.79%. Perrigo Company's quarterly revenue was down 11.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.32 earnings per share. View Perrigo Company's Earnings History.

What guidance has Perrigo Company issued on next quarter's earnings?

Perrigo Company updated its FY17 earnings guidance on Tuesday, May, 30th. The company provided earnings per share guidance of $4.15-4.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.30. The company issued revenue guidance of $4.6-4.8 billion, compared to the consensus revenue estimate of $4.78 billion.

Where is Perrigo Company's stock going? Where will Perrigo Company's stock price be in 2017?

15 equities research analysts have issued 1-year target prices for Perrigo Company's shares. Their predictions range from $60.00 to $125.00. On average, they expect Perrigo Company's stock price to reach $81.85 in the next twelve months. View Analyst Ratings for Perrigo Company.

What are analysts saying about Perrigo Company stock?

Here are some recent quotes from research analysts about Perrigo Company stock:

  • 1. Canaccord Genuity analysts commented, "Date and time of first dissemination: May 22, 2017, 23:13 ET Date and time of production: May 22, 2017, 22:26 ET Target Price / Valuation Methodology: Perrigo Company – PRGO Discounted cash flow analysis supports an $86 valuation for PRGO shares Our discounted cash flow (DCF) analysis leads us to a price target of $86/share for PRGO. Our DCF considers our estimates through 2021, low-single-digit growth through 2033 and zero terminal growth thereafter. In addition, we expect Perrigo’s margin structure to remain somewhat consistent with our 2021 estimates." (5/22/2017)
  • 2. Deutsche Bank AG analysts commented, "We updated our model to reflect PRGO's divestiture of the Tysabri royalty stream to Royalty Pharma, which the company expects to complete this month, and preliminary assumptions for de-leveraging with the proceeds. The net effect of these changes was EPS dilution of ~15-20% over 2017-21 and a reduction in our DCF-derived PT to $87 (from $93), as our prior model reflected more value for the Tysabri royalty stream (~$3bn) relative to the upfront payment of $2.2bn. We have not factored in the potential sales-based milestone payments of $650mn, which could add ~$4/share to the theoretical DCF value if they hit. We continue to view PRGO as a unique asset with good value creation potential over the longer term, and are maintaining our Buy rating. Solid execution in the coming quarters will be critical for the stock, in our view." (3/14/2017)
  • 3. Jefferies Group LLC analysts commented, "Unaudited Q4 results were ahead of forecast. But the real story is FY17 guidance and it disappointed even after sharp cuts to Street models just 4 weeks ago. For the first time we can recall both rev & EPS will decline ' not a good story line for an OTC-focused company. Tysabri's sale helps de-lever PRGO but at the same time shrinks the EPS base by ~$2.20. Mgt continues to make moves to enhance shareholder value ' but it may take quite some time to do so." (2/28/2017)
  • 4. Royal Bank Of Canada analysts commented, "While we expected a challenging 2017 guide, it was worse than we anticipated and came with an unexpected CFO departure. The strategic review around whether to sell Rx/generics will linger, limiting visibility but the conundrum is that we do not see upside in either scenario. We remain on the sidelines with target down to $68. Several additional thoughts after speaking with management this evening." (2/28/2017)
  • 5. According to Zacks Investment Research, "Perrigo has a presence in the OTC market and sells generic and specialty pharma drugs as well. We are positive on the company’s focus on acquisition-driven growth. The Mar 2015 Omega Pharma acquisition has expanded product offerings in the European OTC market. Going forward, we could see more of such merger & acquisition activities at the company. Moreover, the company’s restructuring plans to boost shareholder value look encouraging. However, the company had provided a dull outlook for both 2016 earnings and revenues, which is concerning. The cut in the earnings guidance reflects softness in pricing in the Rx segment due to industry and competitive pressures. The company expects this softness to continue impacting its fundamentals through 2016. The reduction was also due to a weaker performance expected within the BCH segment over the next three quarters as well as low expectations for consolidated new product launches." (7/25/2016)

Who are some of Perrigo Company's key competitors?

Who owns Perrigo Company stock?

Perrigo Company's stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.17%), BlackRock Inc. (8.48%), State Street Corp (4.63%), Aberdeen Asset Management PLC UK (2.11%), Parnassus Investments CA (1.95%) and Manning & Napier Advisors LLC (1.69%). Company insiders that own Perrigo Company stock include Gary K Kunkle Jr, Geoffrey M Parker, Herman Morris Jr, John T Hendrickson, Joseph C Papa, Judy L Brown, Michael J Jandernoa, Sharon Kochan, Thomas Farrington and Todd W Kingma. View Institutional Ownership Trends for Perrigo Company.

Who sold Perrigo Company stock? Who is selling Perrigo Company stock?

Perrigo Company's stock was sold by a variety of institutional investors in the last quarter, including Cornerstone Capital Management Holdings LLC., FMR LLC, Camber Capital Management LLC, Menora Mivtachim Holdings LTD., Los Angeles Capital Management & Equity Research Inc., Morgan Stanley, Manning & Napier Advisors LLC and Highbridge Capital Management LLC. Company insiders that have sold Perrigo Company stock in the last year include Gary K Kunkle Jr, Herman Morris Jr, Judy L Brown and Thomas Farrington. View Insider Buying and Selling for Perrigo Company.

Who bought Perrigo Company stock? Who is buying Perrigo Company stock?

Perrigo Company's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Aberdeen Asset Management PLC UK, Parnassus Investments CA, Vanguard Group Inc., North Tide Capital LLC, State Street Corp, State of New Jersey Common Pension Fund D and Clal Insurance Enterprises Holdings Ltd. View Insider Buying and Selling for Perrigo Company.

How do I buy Perrigo Company stock?

Shares of Perrigo Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Perrigo Company's stock price today?

One share of Perrigo Company stock can currently be purchased for approximately $73.33.

MarketBeat Community Rating for Perrigo Company (NYSE PRGO)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  432 (Vote Outperform)
Underperform Votes:  430 (Vote Underperform)
Total Votes:  862
MarketBeat's community ratings are surveys of what our community members think about Perrigo Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Perrigo Company (NYSE:PRGO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 8 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $81.85 (11.61% upside)

Analysts' Ratings History for Perrigo Company (NYSE:PRGO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/16/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$85.00LowView Rating Details
6/5/2017Royal Bank Of CanadaDowngradeSector Perform -> Underperform$66.00 -> $60.00LowView Rating Details
6/1/2017Barclays PLCReiterated RatingOverweight$100.00 -> $85.00LowView Rating Details
5/31/2017Canaccord GenuitySet Price TargetBuy$80.00LowView Rating Details
5/31/2017Goldman Sachs Group, Inc. (The)Reiterated RatingSell$68.00HighView Rating Details
5/24/2017Jefferies Group LLCReiterated RatingHold$71.00MediumView Rating Details
4/22/2017B. RileyReiterated RatingNeutral$67.00MediumView Rating Details
4/19/2017Deutsche Bank AGLower Price TargetBuy$87.00 -> $86.00LowView Rating Details
4/14/2017Wells Fargo & CompanyReiterated RatingMarket Perform$67.00N/AView Rating Details
2/28/2017GuggenheimReiterated RatingBuy$125.00N/AView Rating Details
11/10/2016J P Morgan Chase & CoSet Price TargetHold$95.00N/AView Rating Details
11/11/2016Bank of America CorporationUpgradeUnderperform -> NeutralN/AView Rating Details
9/27/2016ArgusReiterated RatingHoldN/AView Rating Details
8/10/2016Leerink SwannSet Price TargetHold$96.00 -> $81.00N/AView Rating Details
8/11/2016Northland SecuritiesDowngradeOutperform -> Market Perform$123.00 -> $94.00N/AView Rating Details
6/17/2016BTIG ResearchReiterated RatingNeutralN/AView Rating Details
6/15/2016Raymond James Financial, Inc.Reiterated RatingHoldN/AView Rating Details
5/14/2016Morgan StanleyReiterated RatingHoldN/AView Rating Details
4/25/2016Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
2/22/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
6/23/2015BMO Capital MarketsInitiated CoverageOutperform$246.00N/AView Rating Details
(Data available from 6/22/2015 forward)


Earnings History for Perrigo Company (NYSE:PRGO)
Earnings by Quarter for Perrigo Company (NYSE:PRGO)
Earnings History by Quarter for Perrigo Company (NYSE PRGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/30/2017Q1 17$0.99$1.05$1.19 billion$1.19 billionViewN/AView Earnings Details
5/22/201712/31/2016$1.76$1.24$1.39 billion$1.33 billionViewN/AView Earnings Details
11/10/2016Q316$1.58$1.65$1.28 billion$1.40 billionViewN/AView Earnings Details
8/10/2016Q216$1.98$1.93$1.43 billion$1.48 billionViewListenView Earnings Details
5/12/2016Q116$1.75$1.75$1.35 billion$1.34 billionViewListenView Earnings Details
2/18/2016Q415$1.93$1.80$1.46 billion$1.42 billionViewListenView Earnings Details
10/22/2015Q3$1.73$1.76$1.42 billion$1.34 billionViewListenView Earnings Details
8/5/2015Q2$1.96$2.18$1.52 million$1.53 millionViewN/AView Earnings Details
4/21/2015Q315$1.78$1.85$1.10 billion$1.05 billionViewN/AView Earnings Details
2/5/2015Q215$1.79$1.82$1.09 billion$1.07 billionViewN/AView Earnings Details
11/6/2014Q115$1.44$1.40$997.90 million$951.50 millionViewN/AView Earnings Details
8/14/2014Q414$1.55$1.74$1.09 billion$1.14 billionViewN/AView Earnings Details
5/7/2014Q314$1.51$1.31$1.07 billion$1,000.00 millionViewN/AView Earnings Details
2/6/2014Q214$1.59$1.87$996.68 million$979.00 millionViewN/AView Earnings Details
10/31/2013Q114$1.40$1.52$900.10 million$933.00 millionViewN/AView Earnings Details
8/15/2013Q4 2013$1.56$1.57$999.08 million$967.20 millionViewN/AView Earnings Details
5/7/2013Q3 2013$1.44$1.42$935.44 million$919.83 millionViewN/AView Earnings Details
2/1/2013Q2 2013$1.31$1.36$881.84 million$882.96 millionViewN/AView Earnings Details
11/7/2012Q113$1.24$1.27$825.83 million$769.80 millionViewN/AView Earnings Details
8/16/2012$1.27$1.28ViewN/AView Earnings Details
5/8/2012$1.22$1.41ViewN/AView Earnings Details
2/7/2012$1.15$1.20ViewN/AView Earnings Details
10/27/2011$1.06$1.10ViewN/AView Earnings Details
8/16/2011$0.97$1.02ViewN/AView Earnings Details
5/3/2011$0.97$1.07ViewN/AView Earnings Details
2/1/2011$0.95$1.05ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Perrigo Company (NYSE:PRGO)
Current Year EPS Consensus Estimate: $4.28 EPS
Next Year EPS Consensus Estimate: $5.05 EPS


Current Dividend Information for Perrigo Company (NYSE:PRGO)
Most Recent Dividend:6/13/2017
Annual Dividend:$0.64
Dividend Yield:0.87%
Dividend Growth:17.20% (3 Year Average)
Payout Ratio:-3.90% (Trailing 12 Months of Earnings)
14.95% (Based on This Year's Estimates)
12.67% (Based on Next Year's Estimates)
Track Record:14 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Perrigo Company (NYSE:PRGO)

Dividend History by Quarter for Perrigo Company (NYSE PRGO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Perrigo Company (NYSE:PRGO)
Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 76.52%
Insider Trades by Quarter for Perrigo Company (NYSE:PRGO)
Institutional Ownership by Quarter for Perrigo Company (NYSE:PRGO)
Insider Trades by Quarter for Perrigo Company (NYSE:PRGO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2016Judy L BrownEVPSell2,097$89.44$187,555.68View SEC Filing  
11/21/2016Geoffrey M ParkerDirectorBuy2,500$88.75$221,875.00View SEC Filing  
10/24/2016Judy L BrownEVPSell2,092$90.42$189,158.64View SEC Filing  
9/26/2016Judy L BrownCFOSell2,096$96.76$202,808.96View SEC Filing  
9/26/2016Thomas FarringtonEVPSell1,110$96.76$107,403.60View SEC Filing  
9/9/2016Gary K Kunkle JrDirectorSell5,814$89.95$522,969.30View SEC Filing  
9/8/2016Herman Morris JrDirectorSell1,073$90.96$97,600.08View SEC Filing  
8/26/2016Judy L BrownEVPSell2,095$88.28$184,946.60View SEC Filing  
4/13/2016Judy L BrownCFOSell2,776$126.22$350,386.72View SEC Filing  
3/18/2016Michael J JandernoaDirectorSell761$128.29$97,628.69View SEC Filing  
3/2/2016Sharon KochanEVPSell1,490$125.28$186,667.20View SEC Filing  
2/24/2016Judy L BrownCFOSell2,776$123.73$343,474.48View SEC Filing  
1/6/2016Judy L. BrownCFOSell27,737$142.41$3,950,026.17View SEC Filing  
12/28/2015Joseph C. PapaChairmanSell10,183$147.07$1,497,613.81View SEC Filing  
8/25/2015John T. HendricksonEVPSell1,737$181.37$315,039.69View SEC Filing  
8/25/2015Todd W. KingmaVPSell1,715$181.37$311,049.55View SEC Filing  
8/24/2015John T. HendricksonEVPSell4,468$177.68$793,874.24View SEC Filing  
4/29/2015Todd W KingmaVPSell1,700$190.27$323,459.00View SEC Filing  
4/14/2015John T HendricksonEVPSell8,800$200.27$1,762,376.00View SEC Filing  
4/13/2015Todd W KingmaVPSell1,300$198.44$257,972.00View SEC Filing  
3/13/2015Jatin ShahSVPSell2,000$165.50$331,000.00View SEC Filing  
10/1/2014Judy L BrownCFOSell3,515$150.72$529,780.80View SEC Filing  
9/3/2014Sharon KochanEVPSell1,116$150.00$167,400.00View SEC Filing  
9/3/2014Todd W KingmaVPSell2,250$149.65$336,712.50View SEC Filing  
9/2/2014Judy L BrownCFOSell3,515$149.32$524,859.80View SEC Filing  
9/2/2014Thomas FarringtonVPSell1,741$150.36$261,776.76View SEC Filing  
8/27/2014Michael Robert StewartVPSell4,519$148.78$672,336.82View SEC Filing  
8/26/2014Jeffrey NeedhamVPSell10,205$148.54$1,515,850.70View SEC Filing  
8/26/2014Judy L BrownCFOSell4,827$148.87$718,595.49View SEC Filing  
8/25/2014John T HendricksonEVPSell2,533$148.44$375,998.52View SEC Filing  
5/15/2014Ran GottfriedDirectorSell1,000$131.25$131,250.00View SEC Filing  
3/24/2014Joseph PapaChairmanSell10,000$157.72$1,577,200.00View SEC Filing  
1/16/2014Joseph PapaChairmanSell5,000$157.59$787,950.00View SEC Filing  
12/12/2013Gary CohenDirectorSell4,632$152.52$706,472.64View SEC Filing  
12/12/2013Joseph PapaChairmanSell15,000$150.12$2,251,800.00View SEC Filing  
12/9/2013Michael JandernoaDirectorSell128,620$155.30$19,974,686.00View SEC Filing  
11/25/2013Louis YuVPSell2,292$155.51$356,428.92View SEC Filing  
11/21/2013Judy BrownCFOSell9,988$154.74$1,545,543.12View SEC Filing  
11/20/2013John HendricksonEVPSell8,400$152.80$1,283,520.00View SEC Filing  
11/4/2013Ran GottfriedDirectorSell2,275$143.36$326,144.00View SEC Filing  
9/24/2013Joseph PapaChairmanSell15,000$124.60$1,869,000.00View SEC Filing  
9/18/2013John HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
9/11/2013Michael Robert StewartVPSell5,063$123.37$624,622.31View SEC Filing  
9/9/2013Louis YuVPSell1,852$124.11$229,851.72View SEC Filing  
9/6/2013John T HendricksonEVPSell1,000$123.46$123,460.00View SEC Filing  
9/4/2013John T HendricksonEVPSell2,000$123.92$247,840.00View SEC Filing  
9/3/2013Judy BrownCFOSell2,500$122.07$305,175.00View SEC Filing  
8/30/2013Jeffrey NeedhamVPSell6,585$120.47$793,294.95View SEC Filing  
8/29/2013Sharon KochanVPSell3,467$120.98$419,437.66View SEC Filing  
8/27/2013Joseph PapaChairmanSell15,000$117.64$1,764,600.00View SEC Filing  
8/26/2013John HendricksonEVPSell2,099$119.15$250,095.85View SEC Filing  
8/26/2013Judy BrownCFOSell3,424$119.28$408,414.72View SEC Filing  
8/20/2013John HendricksonEVPSell1,676$118.56$198,706.56View SEC Filing  
8/20/2013Judy BrownCFOSell2,804$118.58$332,498.32View SEC Filing  
8/20/2013Thomas FarringtonVPSell1,658$119.86$198,727.88View SEC Filing  
8/16/2013Todd KingmaVPSell1,250$120.00$150,000.00View SEC Filing  
7/19/2013Todd W KingmaVPSell1,250$129.37$161,712.50View SEC Filing  
7/11/2013Joseph C PapaChairmanSell10,000$128.54$1,285,400.00View SEC Filing  
7/9/2013John T HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
6/14/2013Joseph C PapaChairmanSell10,000$118.39$1,183,900.00View SEC Filing  
6/14/2013Todd W KingmaVPSell1,250$118.00$147,500.00View SEC Filing  
6/4/2013Judy L BrownCFOSell2,500$116.38$290,950.00View SEC Filing  
5/14/2013Sharon KochanVPSell2,647$119.64$316,687.08View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Perrigo Company (NYSE:PRGO)
Latest Headlines for Perrigo Company (NYSE:PRGO)
DateHeadline logoPerrigo (PRGO) Launches Generic Equivalents to Derma-Smoothe/FS Scalp Oil and Body Oil - June 22 at 7:54 AM logoPerrigo Announces the Launch of Generic Equivalents to Derma-Smoothe/FS® Scalp Oil and Body Oil - June 22 at 7:54 AM logoPerrigo Company Retains Spencer Stuart for CEO Search - June 22 at 7:54 AM logoEarnings Highlights and Review: Perrigo Reported Better-than-Expected Quarterly Results - June 21 at 2:02 AM logoPerrigo Company (PRGO) Upgraded at BidaskClub - June 20 at 4:46 PM logoPerrigo Company (PRGO) Receives Consensus Rating of "Hold" from Analysts - June 20 at 12:30 PM logoPerrigo Announces the Launch of Hydrocodone Bitartrate and Homatropine ... - June 20 at 1:14 AM logoPerrigo Announces the Launch of Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution - June 19 at 10:19 AM logo$1.18 Billion in Sales Expected for Perrigo Company (PRGO) This Quarter - June 16 at 1:54 PM logoPerrigo Company (PRGO) Now Covered by Cantor Fitzgerald - June 16 at 10:06 AM logoETFs with exposure to Perrigo Co. Plc : June 15, 2017 - June 16 at 9:05 AM logoPerrigo Company To Present At The 17th Annual Oppenheimer Consumer Conference - June 14 at 11:49 PM logoPerrigo Co. Plc :PRGO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 - June 14 at 11:49 PM logoPerrigo Company plc Announces Pricing for its Cash Tender Offer - June 14 at 11:49 PM logoPerrigo Company (PRGO) Expected to Announce Earnings of $0.94 Per Share - June 14 at 6:20 PM logoPerrigo Company plc Announces Early Tender Results for Cash Tender Offer - June 14 at 8:45 AM logoComparing USANA Health Sciences (USNA) & Perrigo Company (PRGO) - June 13 at 4:49 PM logoStruggling Generic Drugmakers Face M&A Dilemma: Expand and Complicate or Stand Pat and Risk It All - June 11 at 7:35 PM logoHead-To-Head Review: Perrigo Company plc (PRGO) & USANA Health Sciences (USNA) - June 9 at 10:32 PM logoPerrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : June 9, 2017 - June 9 at 7:31 PM logoSmall is lucrative for Wachtell, corporate America's legal defense force - June 8 at 9:00 AM logoPerrigo Company plc (PRGO) & USANA Health Sciences (USNA) Head to Head Review - June 8 at 7:58 AM logoPRESS DIGEST - Wall Street Journal - June 6 - June 7 at 7:15 PM logoDISH to pay $280M in telemarking lawsuit - June 6 at 8:03 AM logoUS STOCKS-Futures slip as investors turn risk averse - June 6 at 8:03 AM logoDrugmaker Perrigo says CEO Hendrickson plans to retire - Reuters - June 6 at 12:58 AM logoPerrigo Announces Forthcoming Retirement Of CEO John Hendrickson - June 5 at 7:57 PM logoPerrigo says CEO Hendrickson to retire, search committee created - June 5 at 7:57 PM logoDrugmaker Perrigo says CEO Hendrickson plans to retire - June 5 at 7:57 PM logo[$$] Perrigo CEO to Leave After 14 Months - June 5 at 7:57 PM logoRoyal Bank of Canada Lowers Perrigo Company plc (PRGO) to Underperform - June 5 at 7:56 AM logoValuEngine Lowers Perrigo Company plc (PRGO) to Hold - June 3 at 2:34 PM logoPerrigo Company To Present At The Jefferies 2017 Healthcare Conference - June 2 at 9:59 PM logoAdjustments to Model for Perrigo, Fair Value Unchanged - June 2 at 1:15 AM logoEdited Transcript of PRGO earnings conference call or presentation 31-May-17 12:30pm GMT - June 2 at 1:15 AM logoPerrigo Company plc (PRGO) Given a $80.00 Price Target at Canaccord Genuity - June 1 at 11:02 PM logoPerrigo Company plc (PRGO) Earns Overweight Rating from Barclays PLC - June 1 at 6:10 PM logoMiracle Cure a Long Shot for Perrigo - June 1 at 2:27 AM logoPerrigo (PRGO) Files Form 10-Q; Reports Q1 Results - May 31 at 11:27 PM logoPerrigo: There Goes the Overhang! - May 31 at 11:27 PM logoPerrigo Stock Jumps on 1Q Beat - May 31 at 11:27 PM logoThe Hot Stock: Perrigo Jumps 7.3% - May 31 at 11:27 PM logoPerrigo Company plc Files First Quarter 2017 Form 10-Q And Reports First Quarter 2017 Financial Results - PR Newswire (press release) - May 31 at 6:25 PM logoPerrigo's (PRGO) Q1 Earnings Beat Estimates, Guidance Intact - May 31 at 1:05 PM logoPerrigo Company plc Announces $1,400,000,000 Cash Tender Offer for Certain Notes - May 31 at 1:05 PM logo[$$] Miracle Cure a Long Shot for Perrigo - May 31 at 1:05 PM logoPerrigo Company plc (PRGO) Earns Sell Rating from Goldman Sachs Group Inc - May 31 at 9:23 AM logoPerrigo Company plc (PRGO) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS - May 30 at 9:24 PM logoPerrigo Company plc (PRGO) Updates FY17 Earnings Guidance - May 30 at 9:24 PM logoPerrigo Company plc Files First Quarter 2017 Form 10-Q And Reports First Quarter 2017 Financial Results - May 30 at 7:00 PM



Perrigo Company (PRGO) Chart for Thursday, June, 22, 2017

This page was last updated on 6/22/2017 by Staff